Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3Sameer A. Greenall(Hudson Institute of Medical Research), Timothy E. Adams(The University of Melbourne)Translational OncologyJune 22, 201810.1016/j.tranon.2018.05.011Cited by 8SaveCiteExport RISWatch citationsRelated PapersNon-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET|PLoS ONE|2012|30